Co-amorphization for solubility and dissolution rate improvement: the case of low-crystallization-tendency drugs. [PDF]
Budiman A +10 more
europepmc +1 more source
Development of an adult whole-body PBPK model of irinotecan and its metabolites for predicting UGT1A1/CYP3A-mediated drug-drug interactions. [PDF]
Chen B +9 more
europepmc +1 more source
Economic Burden and Cost Differences Between Branded and Generic Topical Antifungals in India. [PDF]
Dt P +7 more
europepmc +1 more source
Onychomycosis caused by <i>Syncephalastrum</i> species in a patient with Crohn's Disease in Iraq: A case report. [PDF]
Saadullah AA, Kwizera R.
europepmc +1 more source
The GET pathway modulates azole susceptibility through sterol metabolic remodeling and protein trafficking in filamentous fungi. [PDF]
Ye S +7 more
europepmc +1 more source
Advances in Azole Antifungal Agents: From Structural Foundations to Resistance Challenges. [PDF]
Yin Y, Lu W, Zhao M, Zhao Y.
europepmc +1 more source
Etomidate is a potential medical option in the management of severe and refractory Cushing's syndrome. [PDF]
Tharavath V +5 more
europepmc +1 more source
In Vitro Azole Susceptibility of <i>Malassezia globosa</i> Isolates from Healthy Controls, Atopic Dermatitis, and Pityriasis Versicolor Across Anatomical Sites. [PDF]
Yu Y +6 more
europepmc +1 more source
Comparison of the Effectiveness of Ivermectin 1% Cream and Ketoconazole 2% Cream in Treating Facial Seborrheic Dermatitis: A Double-Blind, Randomized, Controlled Clinical Trial. [PDF]
Sepaskhah M, Shamshiri F, Bagheri Z.
europepmc +1 more source

